Ledger.Open graph →
SEC Form D · filed August 18, 2015

Editas Medicine, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Alexandra Glucksmann · Cambridge, MAExecAlexis Borisy · Cambrige, MADirectorBoris Nikolic · Cambridge, MADirectorAndrew Hack · Cambridge, MAExecVic Myer · Cambridge, MAExecKevin Bitterman · Cambridge, MADirectorKevin Bitterman · Waltham, MADirectorVic Myer · Cambridge, MAExecAlexandra Glucksmann · Cambridge, MAExecDouglas Cole · Cambridg, MADirectorAndrew Hack · Cambridge, MAExecDouglas Cole · Cambridge, MADirectorKatrine Bosley · Waltham, MAExec · DirectorKatrine Bosley · Cambridge, MAExec · DirectorAlexis Borisy · Boston, MADirectorBoris Nikolic · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗